About: Effects of PYY1–36 and PYY3–36 on appetite, energy intake, energy expenditure, glucose and fat metabolism in obese and lean subjects

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Effects of PYY1–36 and PYY3–36 on appetite, energy intake, energy expenditure, glucose and fat metabolism in obese and lean subjects Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 05 December 2006

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у квітні 2007 (uk) im Dezember 2006 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 05 December 2006 (en) artículu científicu espublizáu n'avientu de 2006 (ast) գիտական հոդված հրատարակված 2006 թվականի դեկտեմբերի 5-ին (hy)
publication date	wds:Q58448409-A6FCC524-EB56-4A53-88E5-3CCF80841FBE
publication date	2006-12-05 00:00:00Z (xsd:dateTime)
cites work	wds:Q58448409-02E0783A-81E8-4B60-8747-7D76E83AE3F9 wds:Q58448409-06915ECB-5BAE-411A-B18B-9943EF21743F wds:Q58448409-1944769E-5581-4202-83EE-DBDEF5578ACE wds:Q58448409-244467B3-A7E4-4092-ADE4-C62668AE58F2 wds:Q58448409-2E1FD239-5A87-49DD-9850-F2BF4790B385 wds:Q58448409-3B40C5E3-FFE5-46BE-94CF-49055345C3B2 wds:Q58448409-3F898985-6016-4822-9CCB-E5D450256ECB wds:Q58448409-56548D95-0F00-4DDA-92EA-77FF5C97BB1D wds:Q58448409-5BA2F140-B21C-4EF2-8C41-6C2E941EE3BF wds:Q58448409-75426AA8-196C-4737-98F4-F618538272AE wds:Q58448409-77CEB930-8660-40D2-B4B4-12AF44A08633 wds:Q58448409-8127204B-7ACB-4DE4-AA65-A35FE12E55A2 wds:Q58448409-93601D8B-93A2-41C4-9446-1E26A628AAD5 wds:Q58448409-B2276993-FE2D-4F35-9641-801BE5D442A5 wds:Q58448409-CB8C6891-280F-4AC5-9113-644F25FEFB5A wds:Q58448409-F3479C6C-559E-405D-95BD-351B332BB9AD
cites work	Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: comparison of wild-type, Y1 receptor-deficient, and Y5 receptor-deficient mice Effect of peptide YY3-36 on food intake in humans Intravenous infusion of peptide YY(3-36) potently inhibits food intake in rats Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively. The gut and regulation of body weight A receptor subtype involved in neuropeptide-Y-induced food intake Evidence for neuropeptide Y mediation of eating produced by food deprivation and for a variant of the Y1 receptor mediating this peptide's effect Attenuated peptide YY release in obese subjects is associated with reduced satiety. New methods for calculating metabolic rate with special reference to protein metabolism Obesity: keeping hunger at bay. Gut hormone PYY(3-36) physiologically inhibits food intake Plasma levels of peptide YY correlate with cisplatin-induced emesis in dogs Inhibition of food intake in obese subjects by peptide YY3-36 Human distribution and release of a putative new gut hormone, peptide YY Similar elimination rates of glucagon-like peptide-1 in obese type 2 diabetic patients and healthy subjects Peptide YY-like immunoreactivity in the central nervous system of the rat.
author name string	wds:Q58448409-D19C0459-13D9-4857-A47D-57C5BD8E2805 wds:Q58448409-E95D25E3-4484-4134-83B0-490140017286 wds:Q58448409-F39E59E1-752A-44A9-8AFA-A2BD330387BA
author name string	Anne Flint Birgitte Sloth Nikolaj Ture Gregersen
rdfs:label	Effects of PYY1–36 and PYY3–36 on appetite, energy intake, energy expenditure, glucose and fat metabolism in obese and lean subjects (en) Effects of PYY1–36 and PYY3–36 on appetite, energy intake, energy expenditure, glucose and fat metabolism in obese and lean subjects (nl)
skos:prefLabel	Effects of PYY1–36 and PYY3–36 on appetite, energy intake, energy expenditure, glucose and fat metabolism in obese and lean subjects (en) Effects of PYY1–36 and PYY3–36 on appetite, energy intake, energy expenditure, glucose and fat metabolism in obese and lean subjects (nl)
name	Effects of PYY1–36 and PYY3–36 on appetite, energy intake, energy expenditure, glucose and fat metabolism in obese and lean subjects (en) Effects of PYY1–36 and PYY3–36 on appetite, energy intake, energy expenditure, glucose and fat metabolism in obese and lean subjects (nl)
author	wds:Q58448409-4D47A1A0-C02C-49C7-9BB0-4AD7F730F1A8 wds:Q58448409-A8AAD238-6CAD-4CD3-9871-E7976FB586C2
author	Jens Juul Holst Arne Astrup
title	wds:Q58448409-65A25E77-9F92-4712-8E95-811D9EB0F90D
title	Effects of PYY1-36 and PYY3-36 on appetite, energy intake, energy expenditure, glucose and fat metabolism in obese and lean subjects (en)
page(s)	wds:Q58448409-E51EC78F-87EA-46F4-94AA-CEBD45CE4047
page(s)	E1062-8
instance of	wds:Q58448409-BE394EEA-9AF7-4F8C-8155-1B98A9A3DB43
instance of	scholarly article
main subject	wds:Q58448409-93095511-593A-460C-B3EB-D304B86442FB wds:Q58448409-c9ea45fe-ebeb-4418-8670-bf03d20faed0 wds:Q58448409-cc1b35fd-8a28-431e-9234-5397e3381f5b
main subject	appetite glucose epidemiology of obesity
PubMed ID	wds:Q58448409-819E89B7-DFFF-4629-B882-6A7101D87451
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17148749
PubMed ID	17148749
published in	wds:Q58448409-923D841D-007A-404B-A064-16C037A0B97A
published in	American Journal of Physiology - Endocrinology and Metabolism
issue	wds:Q58448409-EDDDAE0B-89C6-4BAC-86F4-BFADFA30B553
volume	wds:Q58448409-73B175DD-DAB5-4182-9906-3EC59CF8598B
issue	4
volume	292
DOI	wds:Q58448409-B5A00FBA-6AC6-4BDE-95DB-81B4A14996D3
DOI	http://dx.doi.org/10.1152/AJPENDO.00450.2006
DOI	10.1152/AJPENDO.00450.2006
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q58448409
is cites work of	The regulation of food intake by the gut-brain axis: implications for obesity Peptide YY3-36 and 5-hydroxytryptamine mediate emesis induction by trichothecene deoxynivalenol (vomitoxin). Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials Therapy for obesity based on gastrointestinal hormones Mechanisms underlying weight loss after bariatric surgery Differential effects of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on appetite, circulating acyl-ghrelin, peptide YY3-36 and active GLP-1 levels in non-diabetic humans The impact of weight loss on the 24-h profile of circulating peptide YY and its association with 24-h ghrelin in normal weight premenopausal women Peripheral signalling involved in energy homeostasis control Gut hormones in relation to body mass and torpor pattern changes during food restriction and re-feeding in the gray mouse lemur Regulation of energy balance by a gut-brain axis and involvement of the gut microbiota Obesity and appetite control The mechanisms of weight loss after bariatric surgery. Gut hormones: the future of obesity treatment? PYY3-36 and oxyntomodulin can be additive in their effect on food intake in overweight and obese humans. Obesity: considerations about etiology, metabolism, and the use of experimental models Pharmacological management of appetite expression in obesity The use of functional MRI to study appetite control in the CNS. Combination of peptide YY3-36 with GLP-1(7-36) amide causes an increase in first-phase insulin secretion after IV glucose

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software